Site name unknown, Bad Saarow

Phase	Trial	Trial Status [desc]	Site Status	Drug	NCT#
2	Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate	Completed	Closed	Imatinib + RAD001	NCT00510354
2	Treatment of Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumors in First Line With Nilotinib. (OPEN)	Active, not recruiting	Closed	Nilotinib	NCT00756509